Actemra (Tocilizumab) Injection

Description

Description

This page contains brief details about the drug tocilizumab, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

The U.S. FDA approved tocilizumab on 08/01/2010. This medicine belongs to a group of monoclonal antibodies (a protein made from specific immune cells).

Mechanism of Action of Tocilizumab

The medication inhibits the function of a particular protein known as interleukin-6, which plays a role in the body’s inflammatory responses. By blocking this protein, it can help decrease inflammation within your body.

Uses of Tocilizumab

This is used in conditions such as moderate to severe active rheumatoid arthritis (RA) and who have inadequate response with other rheumatoid drugs, giant cell arteritis (disease in arteries), children with systemic juvenile idiopathic arthritis (sJIA), polyarticular juvenile idiopathic arthritis (pJIA).

Tocilizumab Dosage available

The medicine will be administered to you by a healthcare professional in a hospital setting. It is usually administered in the vein (intravenous). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.